Regenerating capacity of Asian Cat fish, Clarias batrachus (Linnaeus, 1758)
Journal: International Journal of Biological Innovations (Vol.4, No. 1)Publication Date: 2022-06-15
Authors : Bibha Chetia Borah; Biswajyoti Bordoloi;
Page : 43-50
Keywords : Biomedical application; Incision; Regeneration; Self-healing; Skin wound; Testis.;
Abstract
In spite of being commercially important and having high market demand, efforts put in for breeding and propagation of the Asian cat fish, Clarias batrachus has not gained the desired momentum as the process demands ablation of the male brood fish for collection of testes. The deep wound so created leads to mortality of the fish resulting in negative impact on broodstock population and farmers' income. Attempts made for post-surgical revival of the fish (weight 110.0-190.0 g/fish) by performing the incision with minimum injury revealed that the fish had amazing capacity of wound healing by regeneration of lost tissue with 83.9-92.6 % (average 87.8%) post-surgical recovery. The incision (4.0-4.5 cm in length) had completely healed within 30-35 days without any medication or stitching. There was post-surgical regeneration of the testicular tissue after 190±10 days in 90% of the randomly sampled fish. Fully developed testes were observed in 86.9% of the samples after 280-310 days of post-surgery rearing. These findings pave the way to address the inherent problem of mortality of male broods vis a vis to explore possible biomedical application of the regenerating capacity of the fish.
Other Latest Articles
- Transplantation of huge trees for construction of piers of magenta metro line and Office-cum-Interpretation Centre in Botanic Garden of Indian Republic, NOIDA
- Brain derived Neurotrophic Factor (BDNF) Val66Met Polymorphism is not risk factor for Bipolar Disorder
- Status of Aquatic Resource and Production of Kongsha River in Northern Bangladesh
- Prevalence of hyperlipidemia in controlled and uncontrolled type-2 diabetic patients
- COVID-19 drugs: A necessary strategy for living with COVID-19 in the new normal and the mutations of the SARS-CoV-2 such as omicron variant
Last modified: 2022-02-01 02:27:05